Interpretation of NCCN Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1.2024) Based on the Current Diagnosis and Treatment Status of China
- VernacularTitle:基于中国诊疗现状的《NCCN指南: 原发性皮肤淋巴瘤(2024年第1版)》解读
- Author:
Shan ZHANG
;
Jie LIU
- Publication Type:Journal Article
- Keywords: primary cutaneous lymphoma; mycosis fungoides; NCCN guidelines; guideline interpretation
- From: Medical Journal of Peking Union Medical College Hospital 2024;15(5):1029-1037
- CountryChina
- Language:Chinese
-
Abstract:
Primary cutaneous lymphomas are a group of non-Hodgkin's lymphomas originating from the skin, with unique clinical and histological features. In December 2023, the National Comprehensive Cancer Network (NCCN) updated and released the
Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1. 2024 ). Compared to the 2023 edition of the Guidelines, this update mainly focuses on the principles of diagnostic assessment, staging criteria, treatment principles for mycosis fungoides(MF) at different stages, and recommendations for radiotherapy. In conjunction with the current situation and characteristics of the diagnosis and treatment of primary cutaneous lymphoma in our country, this article interprets the main recommendations of the Guidelines to promote the application of clinical practices in our country.